Trial Profile
VEST: The UK Vedolizumab Real Life Experience Study in Inflammatory Bowel Disease
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 Sep 2020
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Inflammatory bowel diseases; Ulcerative colitis
- Focus Therapeutic Use
- Acronyms VEST
- 24 Aug 2017 New trial record